AstraZeneca PLC CEDEAR (AZN)
BCBA
Closed
Oct 7, 2026
Day's Range
64,325.0052 wk Range
54,750.00Overview - AZN - AstraZeneca PLC CEDEAR
Key Statistics
Valuation
Enterprise Value
1,891,998.36T
P/E (Trailing)
‪6.68‬
PEG Ratio
‪3.51‬
Price / Sales (TTM)
‪1,703.38‬
Price / Book
‪16.50‬
EV / EBITDA
‪62,997.79‬
Profitability
Gross Margin
‪83.59%‬
Profit Margin
‪17.02%‬
Operating Margin
‪23.45%‬
Return on Assets
‪8.01%‬
Return on Equity
‪21.96%‬
Ownership
Shares Outstanding
1.55B
Float
18.58B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.0060%‬
Price stats
Beta
‪0.20‬
50-Day Avg
‪65,085.00‬
200-Day Avg
‪69,602.63‬
Dividends
Payout Ratio
‪11.97%‬
Frequency
Semi-Annual
Market Cap - AZN - AstraZeneca PLC CEDEAR
Peers - AZN - AstraZeneca PLC CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- AZNBCBAAstraZeneca PLC CEDEAR103.32TMarket Cap+22.93%52-week change6.68P/E (Trailing)‪17.02%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,257.20TMarket Cap+29.46%52-week change57.14P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR353.29TMarket Cap+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR159.66TMarket Cap+22.83%52-week change16.85P/E (Trailing)‪14.52%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt75.56TMarket Cap+22.40%52-week change8.00P/E (Trailing)‪9.80%‬Profit Margin
- GILDBCBAGilead Sciences Inc.75.38TMarket Cap+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.69.12TMarket Cap+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
Profile Summary - AZN - AstraZeneca PLC CEDEAR
About
AstraZeneca PLC CEDEAR is a certificate representing shares of AstraZeneca PLC, a Swedish-British multinational pharmaceutical and biotechnology company headquartered in Cambridge, United Kingdom. The company focuses on the discovery, development, manufacture, and commercialization of prescription medicines across key…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
